Qinghua Zhou Selected Research

Lung Neoplasms (Lung Cancer)

5/2022	Surgical resection versus radiotherapy for clinical stage IA lung cancer ≤1 cm in size: A population-based study.
1/2022	MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
12/2021	Novel Mitochondria-Based Targeting Restores Responsiveness in Therapeutically Resistant Human Lung Cancer Cells.
11/2021	Long-term Lung Cancer Risk Associated with Sputum Atypia: A 27-Year Follow-up Study of an Occupational Lung Screening Cohort in Yunnan, China.
1/2021	Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway.
1/2021	CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung Cancer.
1/2021	Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.
1/2021	Dysregulation of ferroptosis may involve in the development of non-small-cell lung cancer in Xuanwei area.
1/2021	Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma.
11/2020	[Research Advances of m⁶A RNA Methylation in Non-small Cell Lung Cancer].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinghua Zhou Research Topics

Disease

135	Lung Neoplasms (Lung Cancer) 05/2022 - 02/2002
115	Neoplasms (Cancer) 05/2022 - 02/2002
76	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 08/2002
57	Neoplasm Metastasis (Metastasis) 02/2022 - 08/2002
23	Carcinogenesis 01/2020 - 02/2002
19	Adenocarcinoma of Lung 01/2022 - 04/2002
9	Carcinoma (Carcinomatosis) 01/2021 - 04/2002
8	Adenocarcinoma 12/2021 - 04/2004
8	Prostatic Neoplasms (Prostate Cancer) 03/2013 - 04/2006
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 04/2004
4	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2006
3	Liver Neoplasms (Liver Cancer) 01/2021 - 04/2006
3	Inflammation (Inflammations) 06/2019 - 04/2011
3	Malignant Pleural Effusion 02/2019 - 10/2004
3	Lung Diseases (Lung Disease) 01/2016 - 02/2004
3	Exanthema (Rash) 08/2011 - 08/2004
2	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 11/2009
2	Obesity 12/2021 - 06/2019
2	Hepatocellular Carcinoma (Hepatoma) 07/2021 - 12/2009
2	Wounds and Injuries (Trauma) 03/2021 - 12/2019
2	Circulating Neoplastic Cells 11/2020 - 11/2012
2	Infections 01/2020 - 11/2012
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2013
2	Hemorrhage 12/2019 - 09/2017

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
18	Biomarkers (Surrogate Marker)IBA 02/2022 - 08/2008
17	Biological ProductsIBA 01/2022 - 12/2002
16	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2010
15	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2002
13	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2009
13	Messenger RNA (mRNA)IBA 01/2021 - 04/2004
10	Tyrosine Kinase InhibitorsIBA 01/2022 - 12/2009
9	CateninsIBA 01/2018 - 08/2002
8	Cadherins (E-Cadherin)IBA 09/2017 - 08/2002
7	Phosphotransferases (Kinase)IBA 08/2017 - 02/2004
6	EnzymesIBA 01/2021 - 02/2005
5	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2020
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 02/2005
5	Pharmaceutical PreparationsIBA 11/2018 - 03/2010
5	Small Interfering RNA (siRNA)IBA 01/2017 - 05/2010
5	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 04/2002
5	Gefitinib (Iressa)FDA Link 06/2011 - 08/2004
5	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2010 - 02/2002
4	CytokinesIBA 12/2021 - 03/2009
4	Long Noncoding RNAIBA 01/2021 - 01/2015
4	SmokeIBA 02/2018 - 04/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 02/2004
4	Nicotine FDA Link 04/2016 - 09/2011
4	Transcription Factors (Transcription Factor)IBA 04/2013 - 11/2009
4	methylselenic acidIBA 04/2012 - 04/2006
4	SeleniumIBA 04/2012 - 04/2006
4	EndostatinsIBA 08/2005 - 12/2002
3	Complementary DNA (cDNA)IBA 01/2022 - 06/2005
3	AntigensIBA 01/2022 - 01/2011
3	LigandsIBA 12/2021 - 01/2018
3	Monoclonal AntibodiesIBA 07/2021 - 10/2006
3	CarcinogensIBA 01/2019 - 06/2010
3	Interleukin-6 (Interleukin 6)IBA 09/2017 - 08/2010
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2017 - 10/2010
3	LuciferasesIBA 06/2016 - 12/2004
3	Therapeutic UsesIBA 03/2016 - 10/2008
3	AndrogensIBA 03/2012 - 08/2010
3	Androgen Receptors (Androgen Receptor)IBA 02/2011 - 04/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2010 - 12/2009
3	calphostin CIBA 06/2008 - 04/2004
3	tanshinoneIBA 04/2008 - 04/2002
3	hnRNP A2IBA 10/2006 - 04/2004
3	VaccinesIBA 01/2005 - 08/2002
3	Protein Kinases (Protein Kinase)IBA 10/2004 - 02/2004
2	AntibodiesIBA 12/2021 - 01/2019
2	Immunologic Factors (Immunomodulators)IBA 12/2021 - 01/2018
2	Coloring Agents (Dyes)IBA 12/2021 - 10/2009
2	Competitive Endogenous RNAIBA 01/2021 - 01/2020
2	NivolumabIBA 01/2021 - 01/2020
2	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2017
2	mesoglycanIBA 01/2020 - 12/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2019 - 11/2014
2	Blood Substitutes (Artificial Blood)IBA 08/2018 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 05/2009
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 12/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018 - 06/2004
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2017 - 01/2017

Therapy/Procedure

38	Therapeutics 02/2022 - 12/2002
22	Drug Therapy (Chemotherapy) 01/2022 - 08/2002
9	Thoracotomy 01/2022 - 03/2010
8	Radiotherapy 05/2022 - 08/2004
7	Immunotherapy 01/2022 - 11/2018
6	Segmental Mastectomy (Lumpectomy) 05/2022 - 03/2019
6	Lymph Node Excision (Lymph Node Dissection) 02/2020 - 05/2018
6	Castration 03/2013 - 03/2010
3	Adjuvant Chemotherapy 01/2022 - 01/2013
3	Neoadjuvant Therapy 09/2012 - 10/2009
3	Aftercare (After-Treatment) 03/2010 - 04/2004
2	Chemoprevention 11/2021 - 07/2011
2	Ligation 07/2021 - 12/2019
2	Transplantation 01/2021 - 08/2010
2	Contraindications 01/2021 - 02/2006
2	Electrocoagulation (Electrocautery) 12/2019 - 10/2004
2	Sternotomy 08/2018 - 01/2018